These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 10655275

  • 1. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.
    Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, Chiba T.
    Hepatology; 2000 Feb; 31(2):488-95. PubMed ID: 10655275
    [Abstract] [Full Text] [Related]

  • 2. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 3. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH.
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [Abstract] [Full Text] [Related]

  • 4. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD.
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [Abstract] [Full Text] [Related]

  • 6. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 7. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome.
    Rokuhara A, Tanaka E, Yagi S, Mizokami M, Hashikura Y, Kawasaki S, Kiyosawa K.
    J Med Virol; 2000 Dec; 62(4):471-8. PubMed ID: 11074476
    [Abstract] [Full Text] [Related]

  • 8. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 9. Change of hepatitis B virus DNA status in anti-HBc positive liver graft.
    Kwon CH, Suh KS, Cho JY, Yi NJ, Jang JJ, Lee KU.
    Korean J Hepatol; 2006 Jun; 12(2):191-200. PubMed ID: 16804344
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 12. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [Abstract] [Full Text] [Related]

  • 13. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L, Strong DM, Tegtmeier G, Stramer S.
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [Abstract] [Full Text] [Related]

  • 14. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH, Wu JC, Chang TT, Sheen IJ, Huo TI, Lee PC, Su CW, Lee SD.
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [Abstract] [Full Text] [Related]

  • 15. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 16. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L, Koepsell T, Manhart L, Ioannou G.
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [Abstract] [Full Text] [Related]

  • 17. Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.
    Cheung CK, Lo CM, Man K, Lau GK.
    Liver Transpl; 2010 Nov; 16(11):1314-23. PubMed ID: 21031547
    [Abstract] [Full Text] [Related]

  • 18. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
    O'Brien SF, Yi QL, Fan W, Fearon MA, Scalia V, Goldman M.
    Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells.
    Yamamoto M, Hayashi N, Takehara T, Ueda K, Mita E, Tatsumi T, Sasaki Y, Kasahara A, Hori M.
    Hepatology; 1999 Jul; 30(1):300-7. PubMed ID: 10385671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.